Apollomics Inc. (APLMW) SEC Filings — 2024
20 SEC filings for Apollomics Inc. (APLMW) in 2024.
Filings
- Apollomics Inc. Reports Phase 3 Trial Results for Uproleselan — 6-K · Dec 20, 2024
- Apollomics Regains Nasdaq Bid Price Compliance — 6-K · Dec 10, 2024
- Apollomics Holds Shareholder Meeting — 6-K · Nov 14, 2024
- Apollomics Inc. Files 6-K for Shareholder Meeting — 6-K · Nov 1, 2024
- OrbiMed Amends Stake in Apollomics Inc. — SC 13D/A · Aug 15, 2024
- Apollomics Inc. Files 6-K for Q2 2024 — 6-K · Aug 14, 2024
- Apollomics Announces Executive Departures — 6-K · Aug 1, 2024
- Apollomics Gets 180-Day Nasdaq Bid Price Extension — 6-K · Jul 16, 2024
- Apollomics Inc. Updates Strategy and Leadership — 6-K · Jul 3, 2024
- Apollomics Inc. SC 13G/A Filing — SC 13G/A · May 30, 2024
- Apollomics Inc. Launches "At the Market" Sales Program — 6-K · May 24, 2024
- OrbiMed Amends Stake in Apollomics Inc. — SC 13D/A · May 22, 2024
- Apollomics Inc. SC 13G Filing — SC 13G · May 20, 2024
- Apollomics Inc. Enters Private Placement Agreements — 6-K · May 8, 2024
- Apollomics Inc. Updates Investor Presentation — 6-K · Apr 25, 2024
- Apollomics Inc. Files 20-F Annual Report for Fiscal Year Ended December 31, 2023 — 20-F · Mar 28, 2024
- Apollomics Appoints New CFO, Matthew Plunkett — 6-K · Mar 4, 2024
- Apollomics Inc. SC 13G Filing — SC 13G · Feb 27, 2024
- APLM Gets Nasdaq Delisting Warning for Sub-$1.00 Bid Price — 6-K · Jan 19, 2024
- Apollomics Posts New Investor Presentation Materials Online — 6-K · Jan 8, 2024